Categories
Pharmaceutical

Europe to be the Most Attractive Market for Modified Balloon Stent Catheters – Fact.MR Study

According to Fact MR’s recent market research, sales of Modified Balloon Stent Catheters to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Modified Balloon Stent Catheters market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=149

As per latest industry analysis published by Fact.MR, the global stent graft balloon catheter market reached a valuation of around US$ 800 Mn in 2020, which amounts to around 3.5% share of the overall catheter market. Sales of stent graft balloon catheters are slated to rise at a CAGR of 7% to top US$ 1.6 Bn by 2031. Demand for compliant balloon stent catheters is high, and is set to increase at a CAGR of 5% across the assessment period of 2021 to 2031.

Stent Graft Balloon Catheter Market Size in 2020 US$ 800 Mn
Sales Forecast for Stent Graft Balloon Catheters by 2031 US$ 1.6 Bn
Global Market Growth Rate (2021 to 2031) 7% CAGR
Share of Top 5 Companies 50%

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Modified Balloon Stent Catheters market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Modified Balloon Stent Catheters

The report offers actionable and valuable market insights of Modified Balloon Stent Catheters. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Modified Balloon Stent Catheters Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Modified Balloon Stent Catheters, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Modified Balloon Stent Catheters Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=149

Key Segments Covered in Stent Graft Balloon Catheter Industry Research

  • Product Type

    • Compliant Balloon Stent Catheters
    • Non-compliant Balloon Stent Catheters
  • End user

    • Stent Graft Balloon Catheters for Hospitals
    • Stent Graft Balloon Catheters for Ambulatory Surgical Centers
    • Stent Graft Balloon Catheters for Cardiac Catheterization Laboratories
  • Indication

    • Stent Graft Balloon Catheters for Coronary Artery Disease
    • Stent Graft Balloon Catheters for Peripheral Vascular Disease
    • Stent Graft Balloon Catheters for Balloon Angioplasty
    • Stent Graft Balloon Catheters for Bypass Graft Surgery
    • Stent Graft Balloon Catheters for Atherosclerosis Patients
  • Raw Material

    • Polyurethane Stent Graft Balloon Catheters
    • Nylon Stent Graft Balloon Catheters
    • Others

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/149

Competitive Landscape

Expansions, capital investments, R&D activities, technological developments, new product releases, distribution agreements, product portfolio, collaborations, mergers & acquisitions, and strategic alliances are all used by top manufacturers of stent graft balloon catheters.

Top stent graft balloon catheter suppliers have implemented an expansion strategy to increase their production capabilities to meet the growing demand for diverse applications. Several product developments in stent graft balloon catheters are being approved by regulatory bodies for treating vascular diseases.

  • For example, the FDA recently approved an expandable balloon stent graft developed by W.L. Gore & Associates for the treatment of peripheral artery disease.

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

  1. Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
  2. Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
  3. Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
  4. Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
  5. Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
  6. Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
  7. Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
  8. Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.
  9. Key players contributing to growth of the market include Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

Read More Trending Reports of Fact.MR-
https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Modified Balloon Stent Catheters Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Modified Balloon Stent Catheters Historical volume analysis: The report provides a comparison of Modified Balloon Stent Catheters’s historical sales and projected sales performance for 2021-2031.
  • Modified Balloon Stent Catheters Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Modified Balloon Stent Catheters market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Modified Balloon Stent Catheters Consumption by demographics: The report investigates consumer behavior affecting Modified Balloon Stent Catheters demand outlook for the assessment period. Effect of their keenness for digital trends on Modified Balloon Stent Catheters market is carefully analyzed
  • Post COVID consumer spending on Modified Balloon Stent Catheters: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Modified Balloon Stent Catheters market growth.

More Valuable Insights on Modified Balloon Stent Catheters Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Modified Balloon Stent Catheters, Sales and Demand of Modified Balloon Stent Catheters, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

The Stent Graft Balloon Catheter Market To Be A Strong Contender To The Growth Of Healthcare Vertical From 2022 – 2031

The global stent graft balloon catheter market will register a healthy expansion during 2017 to 2022. Revenues from the market are expected to surpass US$ 1,000 Mn by the end of 2022.

Request a report sample to gain valuable insights >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=149

Usually utilized in bypass graft surgery as well as balloon angioplasty, stent graft balloon catheters prevent risks concerning occurrence of re-narrowing in patients undergoing angioplasty, and risks related to abrupt artery closure. Owing to these advantages offered by stent graft balloon catheters, their demand is witnessing a rise. A gradual evolution has been observed in the stent graft balloon catheter market, from the simple stents to modification of balloon stent catheters. Since recent past, there has been a surge in hospital admissions caused by increasing cases of atherosclerosis, and soaring prevalence of CAD – coronary artery disease globally. Numerous developments have been realized in technology of balloon catheters, along with the hike in healthcare expenditure. These factors are expected to augment growth of the market. In contrast, high prices of angioplasty procedures has become a problem for population across developing and underdeveloped economies. This might act as an impeding factor for the market growth.

Growth of the global stent graft balloon catheter market has been highly favored by the advent of drug eluting balloons. In addition, shifting preferences towards using balloons with drug delivery, and helping to deliver medications at local sites, has deemed them to be effective substitutes for administering drugs intravenously. Various new products developed are being approved for treatment of vascular diseases. For instance – recently, the FDA has approved use of expandable balloon stent graft introduced by the W.L. Gore & Associates to treat peripheral artery disease. Moreover, technology advancements in the stent graft balloon catheters, coupled with increasing awareness about angioplasty, and sophisticated healthcare infrastructure in developed economies are further poised to drive the market growth in the near future.

Share Your Requirements & Get Customized Reports >>> https://www.factmr.com/connectus/sample?flag=RC&rep_id=149

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

  1. Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
  2. Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
  3. Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
  4. Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
  5. Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
  6. Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
  7. Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
  8. Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.
  9. Key players contributing to growth of the market include Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

Buy Now – https://www.factmr.com/checkout/149

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Sales of Stent Graft Balloon Catheter In Cardiac Catheterization Laboratories Is Surged with a CAGR of 5.1% By 2022

The global demand for stent graft balloon catheter will register a healthy expansion during 2017 to 2022. Revenues from the market are expected to surpass US$ 1,000 Mn by the end of 2022.

Usually utilized in bypass graft surgery as well as balloon angioplasty, stent graft balloon catheters prevent risks concerning occurrence of re-narrowing in patients undergoing angioplasty, and risks related to abrupt artery closure. Owing to these advantages offered by stent graft balloon catheters, their demand is witnessing a rise. A gradual evolution has been observed in the stent graft balloon catheter market, from the simple stents to modification of balloon stent catheters. Since recent past, there has been a surge in hospital admissions caused by increasing cases of atherosclerosis, and soaring prevalence of CAD – coronary artery disease globally.

Numerous developments have been realized in technology of balloon catheters, along with the hike in healthcare expenditure. These factors are expected to augment growth of the market. In contrast, high prices of angioplasty procedures has become a problem for population across developing and underdeveloped economies. This might act as an impeding factor for the market growth.

To remain ‘ahead’ of your competitors, request a sample

https://www.factmr.com/connectus/sample?flag=S&rep_id=149

Growth of the global stent graft balloon catheter market has been highly favored by the advent of drug eluting balloons. In addition, shifting preferences towards using balloons with drug delivery, and helping to deliver medications at local sites, has deemed them to be effective substitutes for administering drugs intravenously. Various new products developed are being approved for treatment of vascular diseases. For instance – recently, the FDA has approved use of expandable balloon stent graft introduced by the W.L. Gore & Associates to treat peripheral artery disease. Moreover, technology advancements in the stent graft balloon catheters, coupled with increasing awareness about angioplasty, and sophisticated healthcare infrastructure in developed economies are further poised to drive the market growth in the near future.

For critical insights on this market, request for methodology here-

https://www.factmr.com/connectus/sample?flag=RM&rep_id=149

Market Taxonomy

Indication
  • Coronary Artery Disease
  • Peripheral Vascular Disease
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=149

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

  1. Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
  2. Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
  3. Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
  4. Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
  5. Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
  6. Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
  7. Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
  8. Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.Key players contributing to the growth of the market

    Meril Life Sciences Pvt. Ltd. Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

For More Insights

https://www.biospace.com/article/unhealthy-lifestyle-habits-and-improving-awareness-about-new-therapeutics-are-two-key-factors-driving-osteopenia-treatment-market-growth-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com